Disseminated Intravascular Coagulation
Physical Exam Findings
• Depend on primary disease process, the location and severity of fibrin deposition, and the extent of clotting factor depletion
• May not see overt clinical signs in patients with subclinical DIC
Etiology and Pathophysiology
• DIC may be initiated by one of three methods.
• In systemic inflammation, the disrupted endothelium and activated mononuclear cells produce proinflammatory cytokines that initiate an imbalance of coagulation.
• Anticoagulation pathways are inhibited by downregulation of antithrombin III (ATIII), thrombomodulin, and protein C.
• Abnormal coagulation is promoted by consumption of anticlotting factors, including thrombomodulin and antithrombin III.
• Thrombosis causes local ischemia, acidosis, necrosis, and reperfusion injury, which perpetuates DIC and may lead to multiorgan failure.
Diagnosis 

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

